Purchase Order 75N95019P00401
Award Date 7/2/19
Potential Completion Date 11/1/19
Potential Value $81K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Madison, WI 53711, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Brainxell, Inc., a for-profit manufacturer of human neuron cells and related services to support neurological disease research and drug discovery. The contract, valued at $18,725.00, was awarded by the National Institute on Drug Abuse, a part of the National Institutes of Health (NIH), under a small business set-aside. Brainxell will provide human neuron cells, customized neuron cell lines, and associated services to enable research on neuronal infectivity...
- This is a $100,000 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Brainxell, Inc. to provide human cortical glutamatergic neurons derived from induced pluripotent stem cells (iPSCs). The neurons will be used by NCATS' Therapeutics for Rare and Neglected Diseases (TRND) program to study the pathophysiology of NGLY1 deficiency, a rare multi-system disease, and perform high-throughput...
- This $17,575 firm fixed price purchase order was awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the U.S. Department of Health and Human Services, to Brainxell, Inc., a for-profit manufacturer of human neuron cells. The contract is for the provision of CRISPR engineered cells to support neurological disease research and drug discovery. Brainxell has previously received other federal contract and grant awards from NIH institutes for projects...
- The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, awarded a $100,000.00 firm fixed-price purchase order contract to Brainxell, Inc., a for-profit manufacturer of human neuron cells. The contract is for the provision of human cortical glutamatergic neurons to support research on neurological disease and SARS-CoV-2 infectivity. Brainxell, as a prime contractor, has previously received grant awards from...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $135,997 firm-fixed price purchase order to Fujifilm Cellular Dynamics, Inc. to provide induced pluripotent stem cell (iPSC)-derived human midbrain floorplate dopaminergic (iCell DopaNeurons) and glutamatergic (iCell GlutaNeurons) neurons. These fully differentiated neurons will be used in a 3D in vitro circuitry model to evaluate...
- The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), awarded a $86,251 firm-fixed-price purchase order to Fujifilm Cellular Dynamics, Inc. to provide cryopreserved human induced pluripotent stem cell (iPSC)-derived neurons and related supplements. This non-competitive, brand-name acquisition is intended to support neurotoxicity screening assays. The requirement includes iCell DopaNeurons, iCell GlutaNeurons, and other neuronal cell...
- This purchase order awards Fujifilm Cellular Dynamics, Inc. $349,700 for induced pluripotent stem (iPS) cell-derived differentiated cells to support the National Center for Advancing Translational Sciences within the National Institutes of Health's National Institute on Drug Abuse. The contract delivers over 300 units of various iPS cell-derived differentiated cells to develop three-dimensional tissue models of the brain. A pre-solicitation notice sought capability statements for a potential...
- This firm-fixed price purchase order awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Fujifilm Cellular Dynamics, Inc. is for the delivery of 151 kits of iCell Astrocytes and approximately 190 vials of various neuronal cell types. The $583,098 contract calls for the induced pluripotent stem cell-derived differentiated cells to be shipped in three deliveries from March through April 2023 to the National Center for Advancing Translational...
- This federal contract award is for the acquisition of an automatic cell culture station, including a liquid handler, thermoplate, incubator, and live cell imager, by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract was awarded to Cellink LLC, a foreign-owned, for-profit organization, on a firm-fixed price basis for a potential value of $151,928.00. The...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc. for induced pluripotent stem (iPS) cell-derived differentiated cells. The $241,459.53 contract is for the supply of various iPS cell-derived cell types, including dopaminergic, GABAergic, and glutamatergic neurons, as well as endothelial cells, to support the National Center for Advancing...